Criteria for central obesity in a Brazilian population: Impact on the metabolic syndrome;Critério de obesidade central em população Brasileira: Impacto sobre a síndrome metabólica

Arquivos Brasileiros de Cardiologia

Volumn 87, Issue 4, 2006, Pages

  Barbosa, Paulo José Bastos ^a,b   Lessa, Ínes ^a   De Almeida Filho, Naomar ^a   Cunha Magalhães, Lucélia Batista N ^a   Araújo, Jenny ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b NONE   (Brazil)

Author keywords

Brazilian population; Central obesity; Metabolic syndrome; Waist circumference

Indexed keywords

ADULT; ARTICLE; BRAZIL; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; ROC CURVE; URBAN AREA; WAIST CIRCUMFERENCE; ABDOMINAL WALL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; METHODOLOGY; SENSITIVITY AND SPECIFICITY; WAIST HIP RATIO;

ABDOMINAL WALL; ADULT; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; ROC CURVE; SENSITIVITY AND SPECIFICITY; WAIST-HIP RATIO;

EID: 33751353768     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992 Jun;41(6):715-22.
2. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001 Apr;24(4):683-9.
3. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care. 2003 Aug;26(8):2341-4.
4. Rattarasarn C, Leelawattana R, Soonthornpun S, Setasuban W, Thamprasit A, Lim A, et al. Regional abdominal fat distribution in lean and obese Thai type 2 diabetic women: relationships with insulin sensitivity and cardiovascular risk factors. Metabolism. 2003 Nov;52(11):1444-7.
5. Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003 Jan;52(1):172-9.
6. Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C, et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res. 2001 Dec;42(12):2007-14.
7. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002 Oct 14;162(18):2074-9.
8. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans - a 7-year prospective study. Obes Res. 1997 Jan;5(1):16-23.
9. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994 Mar 1;73(7):460-8.
10. Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use. Proceedings of a workshop. 26-27 November 2001. Clin Infect Dis. 2003;37 Suppl 2:S37-153.
11. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. Bmj. 1995 Jul 15;311(6998):158-61.
12. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004 May;27(5):1182-6.
13. Sanchez-Castillo CP, Velazquez-Monroy O, Berber A, Lara-Esqueda A, Tapia-Conyer R, James WP. Anthropometric cutoff points for predicting chronic diseases in the Mexican National Health Survey 2000. Obes Res. 2003 Mar;11(3):442-51.
14. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults - a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003 Jun;60(3):199-204.
15. Steering Committee of the Western Pacific Region of the World Health Organization tlAftSoO, and the International Association for the Study of Obesity, and the International Obesity Task Force. The Asia-Pacific perspective. Redefining Obesity and its Treatment. Health Communications Australia Pty Ltd; 2000.
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005 Oct 25;112(17):2735-52.
17. Lessa I ML, Araújo MJ, Aquino E, Almeida Filho N. Projeto-Monitoramento das Doenças Crônicas Não Transmissíveis (MONIT). Relatório de Pesquisa apresentado ao Centro Nacional de Epidemiologia (CENEPI). Fundação Nacional de Saúde (MS). Brasília - DF; 2000.
18. IBGE. Síntese dos indicadores sociais, 1998. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística (IBGE). 1999.
19. Pitanga FJ, Lessa I. [Anthropometric indexes of obesity as an instrument of screening for high coronary risk in adults in the city of Salvador - Bahia]. Arq Bras Cardiol. 2005 Jul;85(1):26-31.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama. 2003 May 21;289(19):2560-72.
21. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001 May 16;285(19):2486-97.
22. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. Bmj. 1995 Nov 25;311(7017):1401-5.
23. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS. Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic americans. Ann Epidemiol. 2000 Jul;10(5):263-70.
24. Ascaso JF, Romero P, Real JT, Lorente RI, Marti, nez-Valls J, et al. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med. 2003 Mar;14(2):101-6.
25. Ko GT, Chan JC, Woo J, Cockram CS. Waist circumference as a screening measurement for overweight or centrally obese Chinese. Int J Obes Relat Metab Disord. 1996 Aug;20(8):791-2.
26. Lin WY, Lee LT, Chen CY, Lo H, Hsia HH, Liu IL, et al. Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord. 2002 Sep;26(9):1232-8.
27. Li G, Chen X, Jang Y, Wang J, Xing X, Yang W, et al. Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population. Obes Rev. 2002 Aug;3(3):167-72.
28. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama. 2002 Jan 16;287(3):356-9.
29. [I Brazilian guidelines on diagnosis and treatment of metabolic syndrome]. Arq Bras Cardiol. 2005 Apr;84 Suppl 1:1-28.